There’s been a paradigm shift among buy-side companies, which have finally accepted the fact that external R&D is going to be a big part of the future.
Pharmas need to start fine-tuning paid search and producing “liquid content” that moves fluidly between screens, said Google’s David Blair at our first MM&M Skill Sets Live session
Runs and ribbons don’t do much for advanced breast cancer sufferers, survey finds
A Novartis survey finds many women with advanced breast cancer feel left out by an awareness movement focused on prevention, early detection and pink merchandise.
Pharmas dial back reprints spend, floor it on digital to reach HCPs
Pharmas are spending far less on reprints and far more on digital promotion to physicians and other healthcare professionals, according to a healthcare media buying specialist.
Driven by consolidation in the healthcare industry, J&J is reuniting Ethicon, Inc. and Ethicon Endo-Surgery to present surgeons and health systems with a single face.
The FDA wants to know how physician attitudes towards direct-to-consumer advertising have evolved since the agency last asked them, in 2002. If a snap poll by CMI/Compas is any indication, drug companies probably won’t like the answers.